Due to escalating healthcare costs, accurately predicting which patients will incur high costs is an important task for payers and providers of healthcare. High-cost claimants (HiCCs) are patients who have annual costs above $250,000 and who represent just 0.16% of the insured population but currently account for 9% of all healthcare costs. In this study, we aimed to develop a high-performance algorithm to predict HiCCs to inform a novel care management system.
Introduction
It has been known for decades that a relatively small group of patients, termed high-cost claimants (HiCCs), accounts for a disproportionate share of healthcare costs and insurance claims [1] . For example, members with claims over $50,000 per year represented 1.2% of the U.S. insured population but comprised 31% of total spending [2] . In the Medicare population in the U.S., McWilliams and Schwartz [3] found that 17% of the population incurred 75% of all costs. In our comprehensive data on the non-Medicare insured population [4] , members with annual costs greater than $250,000 comprise just 0.1% of the population yet account for 9% of overall costs. Moreover, in this population the number of HiCCs with $250,000 or more has risen by 62% from 36,449 in 2012 to 58,897 in 2016, and the average cost was $446,748 per HiCC in 2017. It is therefore not surprising that when asked to list the most important strategies for healthcare in the next five years, midsized and large employers ranked managing high-cost claimants at the top of the list [5] .
As a population, HiCCs are frequently burdened with multiple chronic diseases, functional limitations, and other barriers [6] . Often, high medical expenditures occur as part of acute or invasive therapies that are frequently unsuccessful and involve tremendous suffering and disability [7] . Fortunately, there are many interventions that could prevent relatively healthy individuals from becoming high-cost claimants in the first place [8, 9] . An intervention is tailored to a member's specific circumstances and might consist of some combination of a telephone call, additional diagnostic studies, referral to a specialist, digital coaching, or other services. Health insurers and providers often maintain a care management organization whose role is to identify patients who would benefit from interventions and match them with intervention programs (Fig. 1) . not based solely on the algorithm's prediction score; rather, the decision is holistic, with the algorithm's prediction score to be considered in the context of the member's overall clinical situation. The intervention is expected to result in some health benefits and cost savings. After the intervention the individual returns to the population.
Because interventions are costly, potential benefits and cost savings that might result from the intervention must be balanced against the cost of the intervention itself [10] . Furthermore, it is challenging to determine which individuals would derive the greatest benefit from the intervention, even within a narrow subpopulation that has a serious pre-existing condition. Therefore, one of the central challenges of a care management program is to identify individuals at risk of acute and expensive health outcomes [8] .
The emergence of powerful predictive AI methods seems ideally suited to address this identification challenge, since an AI algorithm could potentially predict future costs or medical needs at an individual level [11, 12] . Such an identification algorithm can then guide limited intervention resources towards the highest-risk and highest-need individuals. Therefore, our goal here was to apply machine learning to identify members who are at risk of exceeding a total healthcare cost of $250,000 over the next 12 months. We hypothesized that using a relatively large dataset of insurance claims and a large investment in engineering new input variables we could exceed previously published benchmarks in this field.
Overview of existing research
Much research has examined the problems of predicting medical costs and identifying high-cost claimants [12] [13] [14] . However, not many studies used very high-cost thresholds, i.e., studies examining the top 1% (or higher) of claimants. Additionally, many more studies did not report predictive performance in terms of area under the ROC or precision-recall curves, or were descriptive in nature rather than predictive; see Table 1 .
Historically, the problem of high-cost claimants was studied by actuarial scientists at the population level, with emphasis on parameter estimation and statistical significance tests [15] [16] [17] [18] [19] . But with the growing availability of data, computing power, and new artificial intelligence and machine learning methods (AI/ML), there has recently been increased interest in predicting costs at the level of the individual member instead of estimating parameters for populations [13, 20] (for general treatments on the contrast between model-and data-driven methods see [21] [22] [23] ). Table 1 : Summary of studies that used machine learning methods to identify high-cost claimants.
Studies were selected by filtering the list of 55 studies in Table 1 of [14] , and retaining only those studies where the population to be identified was the top 1% or rarer. High-cost claimants above $250,000 have a nearly 100-fold lower prevalence than the top 10% of claimants, posing a much greater predictive challenge. The only study that reported performance values was [24] (area under the ROC curve, AUC-ROC: 81%-86%) and all other studies at this high threshold either did not assess predictive modeling and/or did not report the AUC-ROC.
Study
Population to be identified Model/algorithm Detailed review of previous prediction approaches A common approach to the problem of predicting high-cost claimants is the use of logistic regression. A 2010 paper using logistic regression found that inclusion of medical condition information substantially improved the prediction of high-cost patients, resulting in "good discrimination" (area under the ROC curve, AUC-ROC=0.84%) [38] . The paper also concluded that the number of chronic conditions should be considered as a predictor for high-cost prediction models. In a 2015 study, logistic regression was used to predict which patients would transition from an intermediate-cost subpopulation to a high-cost subpopulation with "reasonable discrimination" (AUC-ROC=0.67%) [39] . Two predictors that were significantly associated with high future costs were the count of chronic conditions and having a diagnosis of congestive heart failure. In a 2017 paper, a group-based trajectory model based on logistic regression was applied to data from a large insurer to accurately predict patients in the highest spending trajectory and the top fifth percentile for spending [40] . Using data from the Danish National Health Service and Civil Registration System, Tamang et al. implemented a penalized logistic regression model with over 1,000 predictors and were able to achieve good predictive performance (AUC-ROC of 0.79%) in a "cost bloom analysis" [41] .
Alternative methods such as machine learning techniques are being applied increasingly to the problem of predicting high-cost claimants. Using neural networks, a 2005 study comparing a population model against three disease-specific models found that larger cohorts tended to result in a greater predictive power of the disease-specific models compared to the population model [42] . A 2013 study using routine electronic service records found that a score based on six simple dichotomous questions had only "fair" predictive power for health and social care costs in elder patients discharged from acute medical units, with an AUC-ROC of 0.70% [43] . A Canadian group [44] applied machine learning to a large range of clinical measurements to identify the top 5% of claimants, attaining an AUC-ROC of 0.81%-0.94%. In a study where an extended gradient boosting model (XGBoost [45] ) was applied on an imbalanced dataset from three of the largest health insurers in the U.S., Hartman found that oversampling the minority class resulted in better predictive performance (AUC-ROC 0.835) than undersampling the majority class [46] , at least at the highest thresholds. Gibbs et al. proposed the use of asymmetric cost matrices to optimize the threshold for an intervention [10] .
Whether one uses logistic regression or alternative machine learning techniques, obvious questions might be (1) which analytic approaches tend to result in the best predictive performance? and (2) which predictors tend to best explain high utilization? A recent review of 55 papers in the literature revealed that high utilization was primarily explained by high levels of chronic and mental illness [14] . Another 2018 literature review concluded that gradient boosting had the best predictive performance overall and for low-to medium-cost members, but neural networks and ridge regression had the highest performance for high-cost members [13] .
Our contribution
In this paper, we describe a novel solution to the problem of identifying future high-cost claimants using machine learning (ML). We applied one of the largest datasets of healthcare insurance claims (over 50 million members), achieving one of the highest performance results reported in the literature reviewed here. Because health insurance plans typically have access only to their own claims data and not to hospital records or specialized registries, we constrained our algorithm to use variables available through health insurance claims alone, along with public data on social determinants of health. No hospital records or specialized registries were used.
Because we anticipated using the predictive model on the full population without any filtering, no requirement regarding continuous enrollment in health insurance was imposed on the data. The algorithm was therefore designed to operate for members with an incomplete medical history, such as less than one year of data. Additionally, the algorithm can function for members for which only medical claims and not pharmaceutical claims are available -a situation occurring in approximately 40% of the insured population in our data.
Similar previous studies most often defined HiCCs using thresholds between $50,000 and $100,000 per
year; some other studies used instead the top 1% to 10% in costs [14] . We instead defined HiCCs as members with a yearly total allowed amount that exceeded $250,000: this is the threshold at which many reinsurance policies attach. At this threshold, high-cost claimants accounted for about 1.6 out of 1,000 members, making identification particularly challenging and requiring truly massive datasets.
Our goal was to identify members who would exceed a total healthcare cost of $250,000 over the next 12 months. Generally, identification of high-cost claimants is modeled typically as a prediction problem in the framework of machine learning. Two formulations are used: (1) predicting cost, namely predicting a member's future dollar cost amount over the next 12 months; or (2) binary classification, namely, predicting whether or not a member will exceed a certain cost amount. We evaluated both of these formulations and then selected the second formulation (classification) after considering the business requirements that are often around a particular threshold and the performance of the models.
Applying our methods to the problem we found that the best performing model overall was the Light Gradient Boosted Trees Classifier (LightGBM) algorithm [47] , achieving an AUC-ROC of 91.25% on a holdout dataset. This is consistent with the findings of a recent literature review [13] , where gradient boosting methods had the best predictive performance overall. The model's AUC-ROC was 7% higher than all previous models at the $250,000 point, and it is estimated that the model's high performance could generate considerable benefits for care management programs.
Methods

Construction of input variables
Our model for predicting health costs was constructed from administrative claims data -the data created as part of electronic exchanges between medical facilities, professionals, and pharmacies on the one side, and payers on the other. In the U.S. the format of claims data is standardized by HIPAA and contains a listing of diagnoses, procedures, drugs, as well as costs. Taken together, claims data provide a nearly complete summary of each patient's medical journey across all types of care. Claims data are readily available to all actors in the healthcare system -the medical insurers, government payers, and sponsors of healthcare -and are increasingly available to patients.
The majority of input variables were calculated from claims data over the one-year report period 4/1/2017 to 3/31/2018, called the "reporting period." The remaining variables, specifically cost trend and some enrollment variables, also included any claims available before the start of the reporting period. If no data were available, we assigned null values. The following one-year interval from 4/1/2018 to 3/31/2019 was considered the "prediction period" and was used to define the high-cost status. At the time of the calculation, claims data were >99% adjudicated.
Predictors were constructed using SQL (Vertica Analytic Database v8.0.1-3; Micro Focus, Berkshire, England, UK). Total allowed amounts for medical conditions (diagnoses) and procedures (services) in the current report period were summed using BHI's Episodes of Care grouper methodology [48] . To prevent information leakage, data were processed in an isolated schema that excluded any events occurring outside the report period. Indicators of social determinants of health were constructed using publicly available data from the U.S. census, estimated for 2017 American Community Survey (ACS) 5-year estimates at the ZIP code level, which were linked to the member based on the member's ZIP code. ACS data included housing conditions, unemployment, poverty and fraction of the population who are a racial minority. Table 2 lists the types of variables used in the prediction. The variables were selected by pruning an initial list of 6,006 variables, which improved the performance. Feature pruning was performed using a feature importance metric available in DataRobot, which implemented a model-agnostic algorithm based on permutation testing. We also used a variable importance metric available in DataRobot, which captured information about tree splitting in tree-based algorithms. To report on model performance, the final model was evaluated on a holdout dataset of 9,684,279 members, described in Tables 3 and 4 , which was not used in the training. The proportion of high-cost claimants (HiCCs) in the holdout reflected the natural proportions in the commercially insured population in the US. A small fraction of the population 65 or older is also was included in this population. We reported the performance on all age and gender groups. Additionally, we further stratified the HiCCs into emergent and recurrent, corresponding to individuals with no previous history of HiCC status, and those who previously were high-cost claimants. These were, in effect, two distinct prediction problems: the emergent population was identified from a very large (N= 48,402,958) set of candidates, whereas the recurrent population was identified in a much smaller set (N= 28,249), of which approximately 37% became HiCCs in subsequent years. Once the automatic selection was complete, we reviewed the model performance on a holdout dataset.
The top model was selected by reviewing each model holistically, including its predictive performance, scoring speed, and interpretability. The model was then subjected to a clinical review and assessment in a separate holdout dataset (see below). We found that we could improve the model's performance by pruning variables of lower importance. We minimized the risk of overfitting by preferring algorithms that are inherently resistant to overfitting such as LightGBM, and by confirming that the model's performance was consistent on the training and holdout data.
Because HiCCs are rare, we used performance metrics that are appropriate for classification problems with class imbalances [50, 51] : area under the ROC Curve (AUC-ROC) and area under the precision-recall curve (AUC-PR). The AUC-PR has been increasingly suggested as the best overall metric of model performance [52] , but we used both metrics since most of the existing literature in the field still uses the AUC-ROC metric. We also computed recall (also called sensitivity and true positive rate), precision (also called positive predictive value), false positive rate, F1 score, and Matthews correlation coefficient (MCC). In production, we applied isotonic regression to obtain calibrated probability scores [53] . The optimal prediction threshold was normally selected using economic analysis (see below) or in other cases, by selecting the score that maximizes the F1 score and the MCC -which agreed within 1% [54] .
The model was deployed both as an API connected to our predictive platform and as an executable Java Archive file (JAR), which can be run in any environment supporting Java (e.g., Linux or Windows). The consistency of the scores of the two implementations was checked to agree numerically to within 0.0001. Model validation used JARs containing the model to calculate prediction scores. The running time of the JAR model is over 400,000 rows per minute. We applied a stringent development and validation process to ensure credibility and accuracy in our recommendations. Our development process and model training are very dependent on iterative clinician review and acceptance by clinical staff.
Also, the internal model validation was conducted by an independent team.
Health economics methods
Going beyond statistical methods for performance, we estimated the financial and health impact of the model. For this estimation, we placed the model in a typical scenario of a care management program in which the model identifies individuals in need of timely interventions [8] . In such a program, individuals with the highest model score are evaluated by clinical experts such as nurses, and if appropriate, enrolled in an intervention program. We compared the identification model to the common care management programs, that often use simple rules to identify members at risk, and therefore have a very high false alert rate.
Because the model is expected to be used in a care management program, the model's probable financial and health impact was assessed in the following care management scenario, which is closely based on our data from multiple health insurers in the U.S. In this scenario, one million members are covered by the insurer, the rate of HiCCs is 0.16%, and the mean cost per HiCC case is $413,975. We assumed an intervention program costs $10,000 per member and achieves an average cost reduction of 15% cost reduction per HiCC. We conservatively did not attempt to estimate the value of the intervention beyond the first year or its effect on non-HiCC members. The care management program has the capacity to treat between 300 and 1000 people per year. The model was considered as a replacement for an existing rule-based HiCC identification system, which was assumed to have a precision of 2%.
Results
Our model training found that highest-performing model was a Light Gradient Boosted Trees Classifier [47] . The classifier uses 410 trees with a maximum of 16 leaves per tree, boosted at a learning rate of 0.05, and with no regularization. The three most important predictor variables are age, a tendency for rising cost in the last three months of the prediction period, and life expectancy based on actuarial tables (see S1 Table) .
When evaluated on the holdout dataset, the algorithm achieves an area under ROC curve of 91.2%, and an area under the precision-recall curve of 23.1% (Figure 2) . At a threshold of 0.76 (consistent with the highest F1 score), the model gives recall of 33.0% and precision of 29.9% (see Table 5 ). The following tables (Tables 6 and 7) show the model's performance in the population of emergent and recurrent HiCCs, namely those with and without prior history of HiCC status, respectively. The AUC of the model is higher in the emergent than the recurrent population (89% vs. 81%) and consistent between gender and demographic cohorts. Members that either (1) lacked data on pharmacy benefits or (2) lacked one full year of data represented 37% and 22% of the population, respectively, yet the model maintained its AUC in these populations to within 1%. TABLE 7 . Shown is the model performance for the recurrent HiCC population. The threshold for a positive class is 0.92, which maximizes the F1 score. AUC is area under the ROC curve; recall is also called true positive rate or sensitivity; FPR is false positive rate; precision is also called positive predictive value; and NPV is negative predictive value. We assessed whether the model possibly under-predicts the number of HiCCs in populations with racial minorities and found no evidence for this. In a univariate analysis correlating the average model score in each ZIP code with the ZIP's fraction of minority population we found a fairly strong positive relationship (R 2 =47%), namely, more HiCC are predicted in areas with higher racial minority. There was no evidence of higher cost in areas of higher racial minority, and indeed the average medical cost tended to be slightly lower in these areas ($1.6 lower for every percentage point increase in minority status).
Health economic analysis
We estimated the financial and health impact of placing the ML algorithm in a typical care management program covering a population of 1 million individuals. In the first step of the program, identification, a subset of the population is identified as likely future high-cost claimants ( Table 8 ). In a representative case, the program has the capacity of 1,000 HiCCs, including 500 recurrent (previously known) and 500 emergent HiCCs, respectively. We set the classification threshold separately for each population and calculated that the algorithm would attain precision of 32% and 66% for the emergent and recurrent cohorts, respectively. To compare the machine learning (ML) algorithm to a conventional rule-based system, we assumed that the program has an overall capacity of 500. The prediction threshold of the algorithm is set to 93% in order to generate 500 members with the highest risk scores. At this threshold, the precision was 39.8%, producing a population of 199 true HiCCs (Table 9 ). By contrast, the rule-based system identified only 10 true HiCCs, and thus the ML algorithm can impact nearly 20 times as many HiCCs. The cost of the program was $5 million in both cases, which translates to a cost per HiCC of $25,125 and $500,000 for the ML algorithm and the rule-based system, respectively. The machine learning-based system would result in a net savings of $7.3 million against a net financial cost of $4.4 million for the rule-based system. 
Discussion
Our study describes an algorithm for identification of high-cost claimants at the level of $250,000 per
year using the methods of machine learning. We demonstrate that using administrative claims with census data alone makes it possible to achieve AUC-ROC scores greater than 90%, even though HiCCs represent only 0.1% of the commercially insured population in the U.S. These results compare very favorably with results published in the literature, which attain performance of 80%-85%, even for populations that are easier to identify. This opens an opportunity to make interventions and achieve significant cost savings. The performance remains essentially unchanged even in populations with limited data, such as partial-year enrollment or lack of drug benefits.
Unlike previous studies that used a single ML method, we applied a modern parallel machine learning platform that considers over 50 models and automatically tuned their hyperparameters. In our experience, the best performing non-ensemble models tended to be the eXtreme Gradient Boosting algorithm [45] and its derivative, the LightGBM [47] . We also found that ensembling (or blending) of models tended to increase performance by 0.2% of AUC-ROC (results not shown here), but these models were not adopted because these gains were outweighed by the increase in computational cost and because they created certain practical barriers to model deployment.
While the literature on predictive models traditionally focuses on AUC-ROC and AUC-PR, in this application a more important measure of performance was the precision (also known as PPV) at the highest-risk 1,000 members. This is simply due to logistics and the extreme rareness of very high-cost claimants. Because the program has a limited enrollment capacity, only the highest-risk HiCCs are referred to this program, and the financial and health outcomes are influenced by the precision in this elite cohort. The algorithm presented here is primarily designed to predict the risk of high cost, rather than measures of health status or health needs. Health is known to be systematically different from cost, and populations with barriers to healthcare, such as lower socio-economic classes or certain racial minorities, have systematically lower healthcare expenditure [55, 56] . Furthermore, the algorithm uses demographic data such as age, gender, and ZIP code-linked variables in order to maximize its predictive performance. Therefore, the most appropriate use of this model is either in a strictly financial setting, or in a holistic care management decision system. Any use of the predictions should be performed by a healthcare professional equipped with rich contextual data because this context would allow the healthcare professional to account for contextual information not available to the algorithm, account for gaps in the algorithm's performance, and ensure equitable outcomes.
Conclusion
The predictive model described demonstrates the potential for the next generation of predictive algorithms for the healthcare space. High-cost claimants exceeding $250,000 in annual cost account for nearly 10% of overall costs but are very rare, representing just 1.6 in every 1,000 members. By using hundreds of variables, rich claims data, and modern machine learning, it was possible to train a machine learning model that attains an AUC-PR of 91% and a precision of more than 30% in the top 1,000 members. With the high predictive performance of this model, cost-effective interventions could be implemented.
Supporting Information   Table S1 . The top 20 input variables of the final model ranked by variable importance. Variable importance was calculated based on the weighted number of tree splits and has been normalized so that the most important variable (AGE) has a relative importance of 1. A total of 255 variables were used in the final model. The allowed amount, sometimes simply referred to as cost, is the cost of care after the settlement between payers and providers. 
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